Hinge Health (NYSE:HNGE) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says

Hinge Health (NYSE:HNGE – Get Free Report) had its price target raised by analysts at Canaccord Genuity Group from $52.00 to $61.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target points to a potential upside of 2.01% from the […]

Leave a Reply

Your email address will not be published.

Previous post Short Interest in Becle, S.A.B. de C.V. (OTCMKTS:BCCLF) Grows By 60.0%
Next post Natixis Advisors LLC Sells 46,721 Shares of Fabrinet (NYSE:FN)